Related Experiment Video
Updated: Apr 28, 2026
06:18
Syntheses, Crystallization, and Spectroscopic Characterization of 3,5-Lutidine N-Oxide Dehydrate
Published on: April 24, 2018
7.9K
Olanzapine use in acute porphyria
1Formerly SHO in Psychiatry, Maudsley Hospital Institute of Psychiatry London.
International Journal of Psychiatry in Clinical Practice
|June 18, 2014
Summary
Olanzapine effectively treated psychotic symptoms in a patient with hereditary coproporphyria. The antipsychotic medication showed a good clinical response without significant adverse effects, indicating its safety and efficacy in acute porphyrias.
Area of Science:
- Neuroscience
- Pharmacology
- Genetics
Background:
- Hereditary coproporphyria is a rare genetic disorder.
- Acute porphyrias can manifest with severe neuropsychiatric symptoms, including psychosis.
- Management of psychotic symptoms in acute porphyrias presents treatment challenges.
Purpose of the Study:
- To report the successful use of olanzapine in managing psychotic symptoms in a patient with hereditary coproporphyria.
- To evaluate the safety and efficacy of olanzapine in this specific patient population.
Main Methods:
- A case report detailing the treatment of a single patient with hereditary coproporphyria.
- Administration of olanzapine for paranoid delusions, poor self-care, and anxiety.
- Clinical observation of patient response and adverse effects.
Main Results:
- The patient experienced a significant improvement in psychotic symptoms after commencing olanzapine.
- No major adverse effects were observed during the treatment period.
- Demonstrated a positive clinical response to olanzapine therapy.
Conclusions:
- Olanzapine appears to be a safe and effective option for treating psychotic symptoms in acute porphyrias.
- This case suggests olanzapine may be a valuable therapeutic agent for neuropsychiatric manifestations of hereditary coproporphyria.
- Further research is warranted to confirm the utility of olanzapine in managing acute porphyrias.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
699
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
699
01:20Antiepileptic Drugs: Potassium Channel Activators
1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
1.0K
01:24Mania and Antimanic Drugs: Overview
793
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
793
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.1K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.1K
01:28Psychosis and Antipsychotic Drugs: Overview
1.2K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.2K
01:21Antipsychotic Drugs: Typical and Atypical Agents
1.3K
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
1.3K